«Devices that monitor blood oxygen levels in the hospital and at home need to be more carefully regulated, a Food and Drug Administration advisory panel indicated at a meeting Tuesday.»

«The devices are everywhere in healthcare settings, and people regularly purchase them for at-home use. But research over the past few decades has steadily shown that they don’t work as well for people with darker skin tones — a disparity that became even more critical during the covid pandemic. The FDA issued an alert saying that the devices have “limitations” in 2021.»

Article written by NICOLE WETSMAN



The Verge